Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

IGI has partnered with AbbVie to grant exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across ...

Glenmark Pharma shares hit upper circuit limit after signing a USD 2 billion deal with AbbVie for a cancer drug. Stock hits ...

New Delhi: Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with ...

US biopharma company AbbVie has inked a $700 million deal with IGI Therapeutics to develop and sell ISB 2001, an experimental drug for blood cancer.

The shares of Glenmark Pharmaceutical Ltd increased 10% on Friday to hit a 52-week high after the company announced that its subsidiary had signed an exclusive license agreement with American ...

A flurry of corporate developments, earnings, and leadership changes are set to drive stock-specific action on July 11. From TCS’s mixed Q1 performance to HUL’s top-level shuffle, and Zee’s capital-ra ...

TCS, IREDA, Glenmark Pharmaceuticals, HUL, Tata Elxsi, and Tata Steel are some of the top stocks to watch today ...

According to MagicBricks, the average price of high-rise apartments on Dwarka Expressway is estimated at ₹14,342 per sq. ft., ...

AM indicate that the Nifty will start the trading day around 131 points lower than it is presently, with dismal Asian trade ...

Stocks including TCS, Hindustan Unilever, Glenmark Pharma, IREDA, Tata Elxsi, Anand Rathi Wealth, Birla Corp, Zee ...